With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Check out this bizarre side effect of EGFR inhibitors, in this case panitumumab. | Goyal & Blaes, N Eng J Med 2020